Lataa...
Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes
IMPORTANCE: Recent studies suggest that dipeptidyl peptidase 4 (DPP-4) inhibitors are associated with an increased risk of developing bullous pemphigoid (BP). Population-based studies on the association between DPP-4 inhibitors and BP are limited. OBJECTIVE: To characterize the potential association...
Tallennettuna:
| Julkaisussa: | JAMA Dermatol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Medical Association
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6439542/ https://ncbi.nlm.nih.gov/pubmed/30624566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.4556 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|